1. Home
  2. CTKB vs AURA Comparison

CTKB vs AURA Comparison

Compare CTKB & AURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cytek Biosciences Inc.

CTKB

Cytek Biosciences Inc.

N/A

Current Price

$6.32

Market Cap

777.3M

Sector

Health Care

ML Signal

N/A

Logo Aura Biosciences Inc.

AURA

Aura Biosciences Inc.

N/A

Current Price

$7.00

Market Cap

631.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CTKB
AURA
Founded
1990
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
777.3M
631.6M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
CTKB
AURA
Price
$6.32
$7.00
Analyst Decision
Buy
Strong Buy
Analyst Count
3
6
Target Price
$6.50
★ $16.60
AVG Volume (30 Days)
★ 1.1M
687.8K
Earning Date
11-04-2026
11-09-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
★ N/A
N/A
Revenue
★ $193,015,000.00
N/A
Revenue This Year
$3.83
N/A
Revenue Next Year
$6.48
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 17.67
N/A
52 Week Low
$3.31
$4.73
52 Week High
$6.34
$9.54

Technical Indicators

Market Signals
Indicator
CTKB
AURA
Relative Strength Index (RSI) 60.02 53.31
Support Level $4.10 $6.65
Resistance Level $6.27 $7.04
Average True Range (ATR) 0.37 0.43
MACD 0.01 0.03
Stochastic Oscillator 86.47 52.78

Price Performance

Historical Comparison
CTKB
AURA

About CTKB Cytek Biosciences Inc.

Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of research and clinical tools with its novel technical approach of leveraging the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its patented FSP technology optimizes sensitivity and accuracy through its optical and electronic designs that utilize an inventive method of light detection and distribution to a specifically selected number and type of detectors. Its FSP cell analyzers, the Cytek Aurora, Northern Lights, and Cytek Aurora Evo systems, deliver high-resolution, high-content and high-sensitivity cell analysis and address the inherent limitations of other technologies.

About AURA Aura Biosciences Inc.

Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.

Share on Social Networks: